GLOBAL RESEARCH ARCHIVE
Takeaways From 2026 Investor Day
Research evidence excerpt
Takeaways From 2026 Investor Day
2027, which should support higher D4 RIN values and an ongoing strong RD Adj. EPS $1.50 $0.82 $4.08 $4.17
margin environment. Higher RD margins likely needed in 2027 to unwind RIN deficit. CFPS $3.10 $4.13 $(0.08) $0.08
Market environment beyond 2027 lacks RVO visibility, but would take big reversal EBIT Margin 7.6% 6.0% 15.9% 15.2%
to revert to down-cycle environment. Even in an extended mid-cycle environment, Consensus Estimates
DAR would be able to generate ~$5B in free cash flow through 2030 -- half of its current
2024A 2025A 2026E 2027E
market cap. Moreover, DAR should build on its mid-cycle EBITDA scenario of $1.6B as 1)
it sees the potential for $150-300mm of internal improvements that are not reflected in EPS $4.35 $4.83
its scenarios and 2) maintains attractive upside opportunity with Nextida (could double Valuation
Food EBITDA over time, but still needs to make a lot of progress). 2024A 2025A 2026E 2027E
Cash returns to shareholders and organic growth investments appear to be post P/E 37.0x NM 15.7x 15.3x
de-leverage capital allocation priorities. Initial pullback in shares likely reflected EV/EBITDA 12.8x 13.4x 7.8x 7.8x
some investors' expectation for concrete buyback/dividend commitment at the event.
P/CFPS 20.6x 15.4x NM NM
However, it likely was too early in de-leveraging timeline for that, but remains central
QTR. EBITDA Q1 Q2 Q3 Q4to longer-term capital allocation strategy. DAR expects to generate enough cash over
the next 2-3 years to pursue both organic growth and cash return to shareholders. 2024A $280 $274 $237 $289
Notably, DAR doesn’t expect to contribute more growth capex to DGD in the near-term 2025A $196 $250 $245 $336
(more market commitments needed for SAF expansion).
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer